drugset / Trial / NCT00615368
Treatment With Erythropoietin and Cognition During Hypoglycaemia
Completed
11 enrolled
Hillerod Hospital, Denmark
Aarhus University Hospital · collabErasmus Medical Center · collabMaastricht University Medical Center · collabRigshospitalet, Denmark · collabSteno Diabetes Center Copenhagen · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of the trial is to determine if erythropoietin (EPO) can enhance cognitive function during hypoglycaemia in patients with type 1 diabetes. Patients with type 1 diabetes will receive one injection of EPO. Hypoglycaemia will be induced 6 days after. Before (1 hour), during and after (1 hour) hypoglycaemia, the cognitive function will be measured.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 40000 iu | Intravenous |